Distance,breastImageneologicalSurveillanceBeginningAtAge
Other,uniqueProperties
Other,mammographicBreastCancerScreening
Other,diagnostics
Polymorphisms,vdrPolymorphisms
Other,shouldPerformedInAtRisk
Other,phosphatase
Disease,elevatedLesion
Other,concurrentNeuroprotectiveDrugTherapy
Other,obtained
Mastectomies,bilateralTotalMastectomies
Other,detectionOfCancer
Hyperglycemia,effectOnBoneRemodelingThroughItsReceptor
Other,mutationCarriers
Other,145Percecnt
Other,extensiveExploration
Disease,tataMemorialCancerHospital
Other,affected
Other,uncommon
Incorporation,study
Other,decision
Other,systems
Other,visualInspection
Other,importance
Other,breastCancerRisk
Other,sentinelLymphNodeBiopsy
Other,descriptive
Other,humanBreastNeoplasmsWithDeregulationOfSeveralMirnas
Other,factors
Other,variousImportantFunctions
Other,medicalDiagnosisOfBreastCancer
Other,total
Other,ssessed
Other,diverseBiologicalProcesses
Dysplasia,zero-inflatedPoissonRegression
Other,comparisonToCa15-3
Other,geneExpressionUpregulationInBreastCancer
Other,93Percecnt
Other,inclusion
Other,91PercecntInPatientsWithBreastTumors
Other,associatedWithPfsAlthoughAtExtent
Similarities,similaritiesOfInformationRequired
Other,sister
Other,scarceReports
Sarcomas,high-gradeSarcomas
Disease,boneTumors
Other,unreported
Other,thriceHigher
Other,hasProven
Dysplasia,regressionModel
Collision,impact
Other,health
Other,population-basedStudies
Other,backgroundTrastuzumab
Other,analysis
Other,them
Other,MRI
Other,cutoffValue
Other,Information
Other,attentionToSpecialGroups
Other,paper
Guidelines,internationalGuidelines
Other,novel
Disease,cancer
Other,indicative
Other,specificAreas
Other,proteinS-100
Other,treatmentOfEuropeanPatients
Incorporation,chicagoStudy
Other,female
Other,advancedComputationalSystems
Other,evenSubgroupOfPatientsTreatedWithRituximab
Craniotomy,forPrecisionResectionUrgentInFieldOfDiagnosis
Other,1984
Other,13Percecnt
Other,considerableNumber
Interval,longPeriodOfTime
Other,patient'sMedicalHistory
Other,generalRadiologistAboutSystemicDiseases
Other,incorrectDiagnosis
Other,rnaOligonucleotides
Other,geneticPredispositionForCancer
Other,compactSynchrotronSources
Other,thenLinkedToTownshipFemaleBreastCancerIncidenceRateIn2000s
Other,minimalRisksToNormalCells
Other,shouldTested
Other,treatmentOfBreastCancer
Other,particularlyPertinent
Other,humanPapillomavirusScreening
Other,alternative
Other,twoPathways
Other,acquisition
Other,glut1Expression
Other,trials
Other,significantAssociationBetweenRs5743810AllelicFrequency
Other,mutationsCarriers
Other,decreasedGrowth
Other,tumorSites
Other,lessLikely
Other,aim
Other,haveUsed
Other,initialTreatmentAfterWhich
Other,limitedHealthSystemCapacities
Other,automatedAnalysisOfClinicallyRelevantHistopathologicFeature
Interference,intervention
Other,invasive
Other,relevant
Other,pax6promoterMethylation
Other,especiallyPost-neoadjuvantTreatment
Other,diagnosisOfBreastCancer
Other,medicalKnowledge
Other,tumorInformation
Other,roles
Other,CRD42016048917
Other,menopause
Cytology,mitochondrialMorphology
Other,SP
Other,breastCancerImagingSetting
Other,ourMethod
Mortality,mortalityRates
Other,newOpportunitiesForDevelopmentOfNovelTherapeuticStrategies
Other,retrospective
Other,diagnosisInMajorityOfInconclusiveCases
Other,features
Other,scalable
Other,recognizingMethylationStatus
Other,significantIncrease
Other,120Patients
Neuropathy,irregularHyperintenseLesionInT2InLeftParietalRegion
Other,cure
Other,selectPatientPopulations
Other,couldPotentialBiomarker
Other,parameterUncertainty
Other,networks
Other,europeanCountries
Other,Kiel
Distance,first
Other,Differentiation
Other,supportVectorMachine
Other,variousOtherCancerInHumanBody
Other,couldSutegorizedIntoT2aWithCutoffValueOf3Cm
Other,intensive
Disease,FIT
Provision,breastCancerControlEffortsForIdentification
Other,imagingFeatures
Other,polymorphismOfFok1
Other,proposedForBreastTumorGrading
Other,riskOfOtherLongTermAdverseHealthSequelae
Other,associationOfToll-likeReceptor6WithBreastCancerInSaudiArabianWomen
Other,biologicalHeterogeneity
Other,usefulness
Other,PFS
Other,needed
Disease,autoimmuneDiseases
Distance,density
Other,oneFamilyAffectedByCs
Other,breastCancerMcf-7
Other,2921Posts
Other,survivalRatesOfLungCancerContinue
Other,made
Neuropathy,lesion
Other,QALY
Interval,note
Other,accurateMethod
Other,designed
Other,35-64Years
Neuropathy,preventionOfChemotherapy-inducedNeuropathy
Other,Japan
Other,undifferentiatedNeoplasticCells
Other,prognosticFactorsOfCancerProgression
Other,restoration
Other,Survival
Other,inception-v3Cnn
Other,howeverLargelyUnreported
Other,taiwanLongitudinalHealthInsuranceDatabase2005
Other,contraceptiveUse
Sleep,age
Consensus,consensus
Other,purpose
Other,ruralSetting
Other,tackled
Other,77Patients
Other,advancedAnalysis
Other,largestReviewOnPrsInAsianPopulation
Scoring,Scoring
Other,severalObjectives
Incorporation,incorporation
Cytology,morphology
Microenvironment,imbalanceInCytokineProfilesInPro-tumorigenicMicroenvironment
Other,severalIndividuals
Other,saudiArabianWomen
Food,multiplexedAssayForDetectionOfAutoantibodiesInCanineTumours
Other,femaleBreastCancerMortality
Other,biopsy
Other,cancerPatients
Aptamer,aptamerMf3
Species,woman
Other,populations
Other,This
Neuropathy,chemotherapy-inducedNeuropathy
Other,components
Other,0-5Years
Other,matthewsCorrelationCoefficientOf8038Percecnt
Carcinoma,Carcinoma
Other,itsRole
Other,appliedTo70PatientsWithUnilateralRl
Other,article
Other,We
Disease,amenorrhea
Other,trastuzumabInitiation
Other,long-termEstimates
Other,concentrations
Other,canDiagnosed
Other,thereforeCentralTarget
Other,20
Other,adultPatientsDiagnosed
Other,medianProgression-freeSurvival
Mother,absorptionImagesAcquiredWithMonochromaticX-raysFromCompactSynchrotronSourceBasedOnInverseComptonScattering
Other,hypomethylationSites
Other,lymphedemaseventyPatients
Other,inexpensive
Other,prognosisOfPatientsWithMaleBreastCancerInShanxiProvinceOfChinaFrom2007To2016
Document,model2
Other,progressionOfSeveralTypesOfNeoplasms
Other,highVariability
Other,suspected
Other,highestSe
Other,tumorSite
Skin,significanceLevel
Other,inheritableBi-objectiveCombinatorialGeneticAlgorithm
Other,multipleBiologicalRolesIncludingParticipationInImmunosuppressiveStudies
Other,costs
Other,broadUseToPatients
Other,whenSevere
Other,anti-oncogenicRegulationOfMir-34s
Other,unusualImmuneProfiles
Disease,triple-negativeBreastCancers
Other,provedByExperimentalEvidence
Gene,growthHormoneReceptor
Other,inhibited
Other,ourFindings
Other,proteinKinaseCInhibition
Other,nuclearFactors
Other,immunohistochemicalAnalysis
Other,inMarch2014BroadcastedAsPart
Other,actualIncidence
Other,couldSutegorized
Other,pragmaticApproachToPopulation-basedCancerScreening
Other,mostCommonNeoplasms
Other,continuousRisk
Other,poorerPrognosisInPatients
Exposure,finiteSamplePerformanceOfProposedMethods
Extract,clearEvidenceForbenefitsOfTanUsageInBreastCancerClassification
Other,differentmethodsOfSelf-treatment
Other,developmentOfBreastCancer
Other,complexSemisolidMasses
Other,AUC
Other,manyWomen
Other,unusualPresentationOfSuperiorVenaCavaSyndrome
Other,Ki67
Other,levels
Other,positiveForGata3In93PercecntIn78PercecntOfCases
Other,morcFamilyCw-typeZincFinger4Overexpression
Other,itEffects
Other,oncoproteins/cancerSuppressors
Other,theirParticularity
Other,invitedInputFromExpertsInSpecificAreas
Other,expressionLevels
Other,three6-monthPeriods
Regions,differentFunctionRegions
Other,dissection
Other,osAdvantage
Other,borders
Other,newFpReductionTechnique
Other,has-miR-3158-3p
Other,comparisonOfPredictedIncidenceOfBreastCancerWithActualIncidenceInPopulation-basedStudies
Other,twoCases
Other,dominantArms
Dysplasia,regressionModels
Sarcomas,softTissueSarcomas
Other,chemotherapy
Other,mostCommonUltrasonographicFindings
Other,figures
Other,searched
Other,problem
Other,evidence
Other,featureFactorsOfPrss
Other,hasMade
Other,third
Other,Risk
Other,risingTrendOfColorectalCancers
Other,effective
Other,idiopathicGranulomatousMastitis
Other,mostTumors
Other,falsePositives
Other,programs
Other,suchLowIncidence
Other,proteinExpressionOfNf-ĸb-p65
Other,mortalityRate
Disease,malignancy
Other,obtainedFromMedicalSpecialists
Other,reports
Neuropathy,possibilityOfEarlyDetectionOfRiskOfOsteoporosisToItsDevelopment
Images,increasedContrast-to-noiseRatioForMonochromaticOverClinicalImagesForWell-definedPhantom
Other,OSs
Other,investigate
Other,especiallyPromising
Other,hdgcTestingCriteria
Interval,excellentPerformanceInFieldOfMedicalImagesDiagnosis
Other,Steps
Other,tumor-bearingMiceOfMcf-7BreastCancerCells
Disease,lymphoma
Other,convolutionalNeuralNetworks
Food,kernelApproach
Document,associationBetweenNsaidsExposureInFemalePatientsWithAd
Other,featureMiningFromRois
Disease,pleuralMetastasis
Other,occurringCancers
Other,etiologyOfManyDiseases
Other,threeParadigmaticExamples
Other,associationWithImagingOfIgm
Other,hasValidatedDatabase
Cytology,surfaceMorphology
Other,furthermoreAssociated
Other,731Percecnt
Other,65Ng/mlForProgranulinFor-1
Other,evenNeeded
Resistance,netvizzApplication
Other,effectsOfTreatment
Other,necessary
Interval,preliminaryGroupOfCtibl
Sarcomas,forty-twoHigh-gradeSarcomas
Exposure,enlargement
Other,quality
Other,0.0001
Quantification,observation
Disease,AD
Relapse,withBetterDrugDeliveryPotentialOfNon-sphericalShapesHaveRecentlyInvestigated
Other,patientsWithMAmongThem
Other,immunocytochemicalStudies
Other,involved
Other,women'sCancerAccounting
Other,aspect
Polymorphisms,occurrenceOfPolymorphisms
Other,knowledgeOfM
Other,RiskProtection
Other,interplay
Other,importantRole
Other,whenPerformedBeforeMenopause
Autoantibodies,autoantibodies
Other,studied
Other,neurocognitiveSequelae
Other,drawbacks
Other,contribution
Other,Irradiation
Other,oncology
Other,patientsWithLocoregionalInSouthernPortuguese
Other,mir-193b-3pBindingTo3UntranslatedRegionOfMorc4
Other,mostlyBilateral
Other,stat1RecruitmentToErαPromoterRegion
Other,rate
Other,CK
Sprays,ddtSprays
Document,threePapers
Chemical,vitaminD
Other,asianCountries
Other,couldDetectedEarly
Disease,Hyperprolactinemia
Other,0.46
Other,tomography
Other,prevention
Other,typical
NSAIDs,NSAIDs
Other,significantEnrichmentOfCdh1MutationsWithinEcDomainsInComparisonToCdh1MutationsAssociatedWithHdgc
Endocrine,imagingOfProstate
Other,systemicChemotherapy
Other,protocol
Inhibition,Inhibition
Skin,alarmingLevelGlobally
Other,dcisDiagnosis
Distance,haveReportedForFirstTimeInCaninesInStudy
Other,ELISA
Interference,theory-basedIntervention
Other,asymptoticPropertiesOfEstimatesCalculatedFrom
Other,opportunitiesForResearchInBreastSurgery
Other,doseConcerns
Distance,firstYearsAfterWithdrawal
Other,hasAssociatedWithPoorCancerScreeningUptake
Other,treatment
Other,prognosisMoreAccurately
Other,lowCountries
Other,bilateral
Other,her2-positiveA
Other,consequentlyPredicted
Surgeons,Surgeons
Other,add-onToConventionalUltrasoundEquipmentApplicable
Guidelines,guidelines
Other,differentiallyExpressedInBreastCancerCells
Other,strongAssociationBetweenRs5743810AgainstRiskInSaudiArabianWomen
Other,responsibleMechanisms
Other,oncogenesEsr1
Other,conjugatedEquineEstrogen
Skin,pax6OverexpressionIncreasingMmp2Andmmp9ExpressionAtMrnaLevel
Other,burdenOfCervicalCancer
Mastectomies,mastectomies
Other,approximated
Other,review
Other,novelInsightsIntoPotentialMechanismsAssociatedWithBreastCancerPathogenesis
Other,lobularCarcinoma
Other,rightMastectomyWithSentinelLymphNodeBiopsy
Other,specimen
Relapse,betterResults
Other,predicted
Other,autosomal-dominantlyInheritedCancerSyndromeAssociatedWithRiskCausedByHeterozygousCdh1GermlineMutations
Other,studiesFocused
Other,simulatedInnerBreastTissue
Macroadenomas,macroadenomas
Similarities,similarities
Provision,pathologyForFurtherFollow-up
Other,thusPresented
Drugs,developmentOfNewDrugs
Other,clinico-epidemiologicalFeaturesOfBreastCancer
Other,ourTheoreticalAnalysis
Other,DAU
Autoantibodies,roleOfAutoantibodiesInEarlyCancerDiagnosis
Other,They
Other,Angiogenesis
Disease,neoplasms
Other,18.791
Other,19
Other,researchDevelopment
Other,hasAssociated
Other,insight
Other,LMICs
Other,NCCN
Disruption,disruption
Other,mainlyEurope
Other,womenAcrossGlobe
Other,patients'Self-monitoring
Disease,breastCancer
Other,actSynergisticallyWithPaclitaxel
Other,value
Other,breastReconstruction
Other,strategies
Other,continuousPattern
Other,were
Food,impairedBaselineCardiacFunctionExperience
Other,modified
Other,higherRatesOfMisdiagnosisForBreastCancer
Other,associationsWithDiseasesLikeTypeI
Plasticity,univariateSensitivityAnalysesresults
Other,oneRegionAnother
Other,therapy
Other,breastScreening
Sleep,medianDiagnosisAge
Appearance,inNumericalSimulationsAccuratelyReconstructedWith90PercecntAccuracyUpToNoiseLevelOf50Percecnt
Other,asianPopulation
Other,adults
Other,january1990
Other,theirContraceptivePreferences
Other,asymptomaticWomen
Gene,SMARCAD1
Other,motivated
Disease,cleftLip/palate
Other,7Percecnt
Other,target
Other,inOfΓ-ggtTransformedIntoNir-sn-nh
Other,adPatients
Other,Prevalence
Probe,nirProbeNir-sn-ggt
Resistance,moreImportantlyCanNowComplementedByEmergingDeepLearningTechniquesForFurtherProcessAutomation
Other,patientsWithBreastCancer
Other,inhibition
Other,miRNA
Other,available
Craniotomy,incompleteExcisionOfMalignantTissues
Other,limitations
Other,defined
Disease,nausea
Other,shown
Other,care
Disease,infertility
Other,89Participants
Other,radiation
Other,breastBiopsies
Other,informationNeeds
Document,modelAccount
Other,recentlyDevelopedBreastImagingTechnique
Other,Cells
Other,breastCancerScreening
Other,whereFacilitatedBySurfaceModificationOfNps
Resistance,application
Other,mammograms
Provision,activation
Document,improvedDiagnosticContentOverEx-vivoClinicalMammographyImagesAtLowerDose
Disease,superiorVenaCavaSyndrome
Other,10Percecnt
Users,12331Non-nsaidUsers
Interval,correspondingHistologyImage
Other,association
Other,microRNA
Other,analysed
Skin,needForAwarenessOfMimicsOfBoneMetastasis
Other,25-year-oldWoman
Disease,collisionTumor
Other,explored
Other,thusCritical
Other,willLeadToMortalityReductionsWithoutUsualScreeningHarms
Other,method
Distance,itsFirstDescription
Other,haveCenterstage
Other,1
Other,thatOfOtherCountries
Other,sample
Distance,firstDose
Other,otherData
Other,alternativeOption
Interval,keyHypomethylationSites
Interference,scalableIntervention
Other,pathogenesisOfBreastCancer
Markers,markersOfMesothelioma
Other,microRNAs
Other,99PercecntOfCases
Interval,keyRole
Other,greatProgress
Other,twoYears
Other,limited-angleFourier-domainSosReconstruction
Sleep,secondDecadeAfterDiagnosis
Other,implemented
Chemical,anastrozole
Other,proteinKinaseC/extracellularSignal-regulatedKinasePathwayInSpinalCordInLumbarSegments4-6
Other,body
Other,solubleMediators
Other,METHODS
Provision,breastCancerControlEfforts
Species,patients
Other,unknown
Polymorphisms,resultsOfIndividualVdrPolymorphisms
Other,sparseCoding
Other,positiveFeedbackLoop
Other,resonanceImaging
Other,epidemiologicalFeatures
Other,existence
Other,singleMetastaticSite
Other,poor
Other,haveAllProposedAmongPotentialPathways
Applicability,applicability
Other,long-termUse
Other,utilized
Other,similarPfs
Other,conclusionsWomen
Other,properAccessToDiagnosis
Other,occurrenceOfBreastCarcinoma
Document,copyright
Obstacle,collectionOfSignsResultingFromObstructionOfSuperiorVenaCavaIncludingSwellingOfUpperBodyOfHead
Other,guidePatients
Appearance,defectStudies
Interference,finalAssessment
Interval,medianLatencyPeriod
Other,breastCancerTissue
Other,shift
Craniotomy,surgicalExcisionWithRadiation
Other,detected
Other,registered
Other,thenShouldTestedForSpecificGeneMutationFound
Food,patientEducationIdentification/reportingOfSideEffects
Other,specificityImprovement
Other,Symptoms
Other,62Years
Species,women
Other,decreasedRiskOfBreastCancerInFemaleAdPatients
Other,circulatingSolubleRankl
Other,theirInteractions
Other,properties
Interval,periodFromApril2012ToDecember2017
Plasticity,massInPosteriorFossaOfBrain
Other,canClassified
Other,mapped
Other,loss
Other,typicallyBilateral
Disease,advancedBreastCancer
Skin,contextOfTwoCasesOfBladder
Other,breastCancerClassification
Baseline,reducedBaselineCardiacFunction
Other,ratio
Exposure,hemorrhagicEnlargement30YearsAfter
Other,top10InformationalNeedContents
Other,7PercecntForCdx2
Other,primaryPurposeOfPeriodicMammogramsInScreeningProgramsIs
Other,0.00001
Disease,carcinoma
Disease,paraneoplasticNeurologicSyndromes
Other,substantialDelayFromDiagnosisToTreatment
Other,Cases
Other,rates
Other,dual-luciferaseReporterAssays
Other,treatmentWithWholeBrainRadiotherapy
Interval,medianFollow-upPeriod
HER-2,caseOfWomanOnNeratinibForHer-2PositiveInfiltratingDuctalCarcinoma
Other,definition
Other,wordCloud
Other,conducted
Other,selected
Other,shouldAnalyzed
Other,predominant
Other,future
Other,reductionOfFpsFrom085002Fp/imageForMias
Other,others
Other,cancerManagement
Other,estimates
Other,neutralEffects
Hyperglycemia,effectOfDdtSpraysOnBreastCancerIncidenceRate
Resistance,suppressionOfCellSurvival
Other,willTested
Other,her2Overexpressing
Other,tissueBiopsy
Other,pax6Overexpression
Other,standardOfCareAsFirst-lineTreatmentOfPatientsWithHer2-positiveAEvenInReal-worldSetting
Chemical,estrogen
Other,downregulated
Other,highMortalityRateForFemales
Other,microrna-22ExpressionLevels
Other,overexpressed
Sleep,duringAgeAssociatedWithIncreaseOf8MoreFemaleBreastCancerCasesPer100
Other,riskOfBreastCancer
Other,determine
Other,indicated
Interval,state-of-the-artImageAnalysisMethods
Incorporation,includedInStudy
Other,c.
Other,medicalHistory
Disease,tumor
Other,initiationOfBreastMalignancy
Other,significant
Other,substantialRacial/ethnicDisparity
Other,couldDetected
Other,referenceForClinicians
Other,urgentClinicalProblem
Disease,heterogeneousDisease
Other,common
Other,improvedCancerTreatment
Other,inspection
Document,model
Other,scope
Relapse,relapse
Other,inflammatoryDiseases
Other,inPreprocessingHasAchieved
Other,itsImportantRoleInEtiologyOfManyDiseases
Other,personalDecision-making
Other,20-year-oldWoman
Other,breastCancerCells
Other,vdrExpression
Other,likely
Other,whenSuspected
Other,hormone-dependentPositiveBreastCancer
Other,included
Other,canOnlyDiagnosedOnPresentationOfSymptoms
Interval,period
Other,usd$901
Other,pax6GeneExpression
Other,developed
Other,mostRelevantKind
Other,hasReduced
Other,992Percecnt
Other,disease
Other,appropriateIntegrationOfPreprocessing
Other,proliferation
Disease,neuropathicPain
Other,mmp2Genes
Other,thepresence
Other,moreoverMostOfTimeBenignRequired
Other,willTestedThroughEuropeanMyPersonalBreastScreening
Disease,primaryBreastDiffuseLargeB-cellLymphoma
Other,dual-energyAcquisition
Other,evenAdjustedForKnownPrognosticFactors
Other,Overexpression
Other,cross-sectionalStudies
Interval,group
Other,68Percecnt
Interval,latencyPeriod
Disease,her-2PositiveBreastCancer
Disease,Prolactinomas
Other,occurring
Other,venaCavaSyndrome
Other,advancedStage
Other,severe
Other,primaryCareProvider
Disease,GDM
Other,worseOsThanT2aSutegory
Other,information
Other,description
Other,fusionProteinsWithHaloTag
Other,shouldCo-managedByCardiologist
Other,criticalImplicationsForTherapeuticDecision-makingInUrothelialCancer
Other,healthySubjects
Other,canClassifiedAsSoluble-proteinBasedImmunocytochemical
Other,relativelyGoodPrognosisWith5YearOverallSurvivalOf88Percecnt
Extract,complementaryBenefit
Appearance,change
Other,408
Other,yetUnclear
Other,longerPfs
Other,nf-ĸb‑inducedIncreasedExpressionOfCcnd1
Other,hypothesis
Other,whereFormulated
Distance,firstSymptom
Other,evaluation
Other,risks
Provision,controlTrial
Other,505Percecnt
Other,30DoublingTimesNecessary
Appearance,case
Images,opticalCoherenceTomographyImages
Other,t2Category
Other,allBreastCancerPatients
Other,dictionaryLearning
Other,twoSutegories
Resistance,characteristicsLikeCapacityForInvasion
Other,access
Disease,hereditaryDiffuseGastricCancer
Other,involvementOfPtenInCs
Other,hematoxylin
Other,xenograftMice
Document,papers
Other,levelsOfErαProtein
Provision,hasReducedThroughoutLastDecades
Other,fission
Other,concernForExistenceOfCancerCellsInGrafts
Other,applied
Other,inBelgiumMostFrequentWomen'sCancerAccountingForTo353PercecntOfCases
Other,potentialTreatmentStrategyForEndocrine-resistantBreastCancers
Other,heterogeneous
Other,worldwideHighestAge-standardizedBreastCancerIncidence
Plasticity,sensitivity
Other,localizedDescriptionOfBreastCancer
Disease,triple-negativeBreastCancer
Other,differentiation
Other,used
Disease,neuropathy
Other,drugBinding
Other,negativeEffects
Other,highPercentageOfRemissionMaintenance
Other,correlated
Other,5-khzFrequencies
Other,hasReported
Other,patientsByTrastuzumab-pretreatment
Other,extensiveAttentionOfResearchers
Provision,2-groupRandomizedControlTrial
Disease,erythema
Other,twoMoieties
Other,hasAchieved
Other,immediateReconstruction
Other,familyMembers
Disease,cyanosis
Other,mostPervasiveTypeOfCancerAmongWomen
Document,literatureForFamiliesWithCdh1Mutations
Other,surgeon
Other,>1500Pg/ml
Other,howeverKnown
Other,additionalInformation
Other,localEntropyMaximizationAlgorithm
Other,mightUseful
Other,denosumabInjection
Other,screeningPrograms
Other,remodeled
Other,adherence
Other,standard
Disease,metastaticDisease
Other,dose
Other,M
Other,comparingWithCurrentStandardMethodOfSubjectiveVisualEstimation
Other,modificationPathways
Other,255Months
Other,morc4Silencing
Other,detection
Distance,firstFiveFacebookOpenBreastCancerGroupsInYear2016
Other,clinicalBreastExaminationCoupledAsPrimaryTool
Other,frequentLateRelapses
Other,pax8AMetastasesOfCancer
Appearance,importanceOfNondestructiveTestingInDefectStudies
Other,greatestImportance
Other,needs
Other,metastasectomy
Resistance,tediousCountingCell
Other,linkage
Other,crucialRole
Other,staining
Other,rituximab
Other,overallCumulativeRiskOfProgression
Other,CGI
Other,moreEasilyHypomethylated
Other,shouldPerformed
Other,widelyUsed
Other,area
Other,mostOfPatientsDuringMammography
Other,risksOfCancerInMutationsCarriers
Other,unnecessarySubsequentExaminations
Other,prohibitivelyExpensive
Other,Lack
Other,oneCancer
Gene,Progranulin
Mutation,rs5743810
Disease,ductalCarcinoma
Other,clinicalSettingOfPreviouslyVagueDiagnosisInImaging
Other,proteinKinaseCInhibitors
Other,township
Other,attention
Dysplasia,finalMultipleRegressionModel
Other,anti-apoptoticEffectsOfEstradiol
Other,t2bSutegory
Other,havePublished
Other,roleOfPdgf-b/pdgfr-betaAxisInRareTypesOfBreastCancers
Other,adherenceToEhtAmongBreastCancerPatients
Endocrine,termsOfProlactinNormalizationInPituitaryFunction
Other,precision
Other,timeOfTheirAppointmentwithDoctor
Other,greatPotentialInDiagnosisTherapyOfCancers
Other,hypomethylation
Other,radiotherapy
Neuropathy,commonPrimaryLesion
Other,differentOss
Other,erαTranscription
Other,hugeVolumes
Disease,RDD
Other,treatedWithIntraperitonealInjectionFor30Days
Other,significantlyDecreased
Incorporation,two-yearStudy
Lymphedema,developmentOfLymphedema
Other,strongLinkage
Other,mostCommonMalignantTumor
Other,SNPs
Other,hasEstablished
Other,identification
Other,us
Other,resultsExpression
Plasticity,massMedia
Plasticity,mass
Interference,chronicDebilitatingLifelongComplication
Other,mammography
Other,currentlyUnclear
Resistance,activity
Other,2-3Years
Other,lumbarSegments4-6
Other,chinesePublic
Provision,rangingFromDiagnosisPhaseToControlOfDisease
Other,connection
Other,magneticResonanceImaging
Other,genesCodingForTumorSuppressorProteins
Other,Areas
Other,yetHasFirmlyEstablishedInClinicalPractice
Food,documentedAsImportantTumor-promotingAgentForSeveralHumanCarcinomasIncludingBreastCancer
Other,feasibilityStudies
Other,adulthood
Incorporation,inStudyDevelopedByCell-selex
Other,associated
Nondestructive,mostNondestructiveTests
Other,approximately75PercecntOfBreastCancers
Other,65Ng/ml
Other,migration
Incorporation,experimentalStudyOfCryo-stabilityOfCancerCells
Other,mayImportantStepsDuringDiagnosis
Other,alternativeToFrozenSections
Baseline,assessedAtBaseline
Other,environmentalFactors
Other,we
Other,twoUncommonCasesOfDelayedBreastCancerRelapses
Other,clinicalPractice
Other,life-threatening
Interval,totalGroup
Other,influences
Other,proposed
Other,easternAsianMusculoskeletalOncologyGroup
Other,collection
Other,diffuseGastricCancerPresentedWithClp
Other,mostCommonCancer
Obstacle,lowerCumulativeHazardRates
Sleep,hadDiagnosedWithBreastCancerAtEarlyAge
Other,this
Other,diagnosticPfBiomarkers
Other,disadvantages
Obstacle,barrierFunction
Neuropathy,poorAdhesion
Other,significantlyReduced
Cytology,aspirationCytology
Other,role
Other,hasDescribedInFewHdgcFamilies
Erythematous,boundErythematousAppearance
Resistance,choiceOfImmunohistochemicalTechniques
Skin,twoCasesOfMimicsOfBoneMetastasis
Other,screening
Other,classificationOfMammograms
Other,muchInterest
Markers,adequateSampleForAnalysisOfMolecularMarkersToGuidePatientsWithNon-smallCellLungCancerToAppropriateTargetedTherapies
Other,mrSystems
Other,Speed-of-sound
Other,alteredInHumanBreastCarcinoma
Other,expressedSeparately
Other,rapidAdvancements
Other,diseases
Other,mortality
Other,automaticIntraoperativeIdentificationOfBreastCancerMargins
Other,normalTissues
Other,breastCancerBrainMetastases
Other,use
Other,ICER
Chemical,Cabergoline
DNA,dnaMethylationDifferencesBetweenTumorBreastTissue
Other,Studies
Other,associationsOfFactorsWithLocoregionalAtDiagnosis
Other,principles
Other,proposedMethod
Other,mostLikelyParaneoplastic
Other,arms
Other,steps
Other,remarkableImprovements
Other,risk
Other,breastCancerGrading
Other,humanBody
Disease,overallSurvival
Other,occultBreastTumors
Other,cross-sectionalCategories
Other,growing
Other,resectedPrimaryLungCancer
Other,challengingProblem
Other,combination
Document,nomogram
Other,textureAnalysis
Gene,Mfn1
Resistance,lungCellCarcinomas
Other,robustSynthesisMethods
Other,independentPrognosticFactor
Other,furtherAdvancements
Other,hasMadeInMolecularSubtypingOfBreastCancer
Other,46NsclcPatientsBeforeChemotherapy
Food,assay
Other,underlyingCauses
Other,concerned
Other,first-lineTreatment
Applicability,clinicalApplicability
Other,grafts
Other,support
Other,correctDiagnosis
Other,inverseProblem
Other,efforts
Other,tumorSuppressorFunction
Other,metastasis-free
Other,radiomics
Appearance,orderOfAppearanceFrequency
Skin,bone
Other,serumCrust
Other,represented
Other,quantitative
Other,advantageOfHigh-throughputLuminexTechnique
Other,mastectomizedWomen
Other,breastCancerIncidence
Other,cancer-relatedDeathsAmongWomen
Other,χ
Distance,shouldIdeallyAdministeredAtLeast1WeekBeforeCommencementOfAlkylatingTreatment
Other,only1ulOfSerumSample
Other,gtpaseInBreastCancerCells
Gene,TTF-1
Other,growthPotential
Other,tumorSuppressorFunctionOfP53InPathogenesisOfBreastCancer
Other,oftenHypomethylated
Other,trastuzumabTherapy
Other,informationalNeedsByCancerType
Chemical,baicalin
Skin,clinicalSecondLevelExamination
Other,willDifferent
Other,hasUsed
Other,oncologyGroup
Other,adipocytes
Extract,mostCommonExtrinsicCause
Other,Review
Provision,cytokineFunctionsLeadingToDevelopmentOfCancers
Other,search
Other,WHI
Other,tnmStaging
Other,largerStudies
Other,retrieved
Other,they
Other,analyzed
Other,mir-193b-3pIdentifiedAsRegulator
Other,haveBackboneOfSuchEnormousStridesOfAu
Other,Israel
Other,centralRoleInBreastCancerResearch
Other,autopsyStudies
Other,potentiallyCurativeRegimensOfCancerChemotherapy
Provision,activationOfOther
Other,successOfSymmetricPositiveDefiniteMatrices
Disease,macroprolactinomas
Other,earlyBreastCancer
Disruption,postponementVisiting
Other,diagnosisSystem
Other,sutegories
Other,numberOfLong-termSurvivors
Other,highlyEffective
Quantification,whole-tumorSamplingOfDiseaseBurden
Skin,balfLevel
Appearance,appearance
Other,testing
Other,risingTrendInMajorityOfLmics
Other,right4
Other,forThoseWithNormalLvef93Percecnt
Other,adjustedProportion
Other,symptomaticWomen
Other,infiltrationSimilar
Covariance,covariance
Other,furtherUnderstanding
Other,healthInitiative
Other,less-effectiveChemotherapyAgents
Other,negativeMargins
Other,challenges
Other,505PercecntOfAnalyzedCases
Other,fewLmics
Other,P
Craniotomy,craniotomy
Other,molecularTesting
Mastectomies,bilateralMastectomies
Probe,probeNir-sn-ggt
Other,thusImportant
Nondestructive,nondestructiveTesting
Other,incrementalCostOfCop$251
Other,highCorrelation
Other,selectedPopulationsOfAfricanPatients
Disease,chorea
Appearance,caseReport
Other,efficacy
Other,breastSurgery
Other,willDifferentRegardingSubtypeAtDiagnosis
Other,associatedWithBreastCancerRisk
Hyperglycemia,highlyProblematicDose-limitingEffect
Chemical,estrogens
Other,simulationStudies
Other,extendedAdjuvantTreatment
Scoring,nuclearAtypiaScoring
Resistance,potentialApplicationForDiagnosisOfCancerInFuture
Distance,focalAsymmetricDensity
Other,inHumanBreastCancerHasReported
Other,rolePlayedByPdgfFamilyMembersInNormalDevelopmentOfBreastTissueDespiteItsPotentPro-lymphangiogenicEffects
Disease,death
Other,interactionEffects
Other,anotherOfSeveralIndividualsInOneFamilyAffectedByCs
Nondestructive,byWhichObservedInNondestructiveWayThroughThermalAnalysis
Document,nsaidsExposure
Other,methylationStatus
Other,interpretation
Other,particularEmphasisQuantifying
Other,capacities
Other,GTPase
Other,cardiotoxicRisk
Other,anticipatedOutcome
Other,expected
Other,survivalDifferences
Other,importantlyCouldPotentialDiagnosticBiomarkerInEthnicPopulation
Disease,heartFailure
Other,commonComplaint
Hyperglycemia,effectOfBaicalinInBreastCancer
Other,experts
Other,exactTest
Other,increases
Other,microscopicTesting
Other,urgent
Aptamer,ssdnaAptamerMf3
Other,number
Other,howeverSwitched
Other,ourPatient
Resistance,cell
Other,pax6MethylationStatus
Malformation,malformationInduction
Other,canStressfulToPatient
Other,commonMedications
Other,byMultivariateAnalysisSignificantIndependentPrognosticFactorOfOs
Other,metastaticDisease
Other,breastCancerDetectionMethod
Other,cancerCare
Other,secondSurgery
Sleep,threeYearsBeforeAge64Years
Other,womenCarriers
Craniotomy,surgicalExcision
Other,characterized
Other,65-year-oldFemale
Disease,cancer-relateddeaths
Other,couldConsidered
Other,PB-DLL
Other,mpMRI
Other,mainContribution
Other,rareCases
Other,randomisedTrials
Other,preventiveStrategies
Other,syndrome
Other,mass/es
Cavernous,cavernousMalformation
Other,linked
Other,predominantlyCystic
Other,continuousDynamicCyclesOfFission
Carcinoma,inflammatoryCarcinoma
Other,developmentOfClinicalDecisionSupportSystemsForBreastCancerDiagnosis
Other,receptorActivator
Probe,remarkableEnzyme-activatedNirFluorescentProbeNir-sn-ggt
Other,plasmaLevels
Other,termsOfKyotoEncyclopediaOfGenes
Other,higherProportion
Other,members
Other,willUsedAsReferences
Other,allow
Other,least
Other,factorsRelatedToPresenceOfMetastaticDiseaseAtDiagnosis
Other,pathways
Users,non-nsaidUsers
Other,ca15-3ByCmia
Other,cystic
Other,vitalRoles
Gene,VDR
Other,size
Other,diagnosis
Other,cells
Other,shouldCo-managed
Chemical,paclitaxel
Other,earlyStageDiagnosisOfTumors
Other,volumes
Resistance,tamoxifenResistance
Other,canStressful
Other,symptom
Other,methodologyOfInstitutoDeEvaluaciónTecnológicaEnSalud
Exposure,reportOnPerformanceOfBayesClassifiersLikeTreeAugmentedNaiveBayes
Other,shapes
Incorporation,ourStudy
Gene,STAT1
Other,roleOfSupportOfferedByVirtualCommunitiesToBreastCancerPatients
Other,typicalFeaturesIncludingFibrocysticBreastDisease
Other,rare
Other,importantAspect
Other,RL
Other,associations
Other,realStatusOfPrs
Other,miRNAs
Other,mastitis
Other,initiationOfPromptTherapy
Other,vitalRole
Other,causes
Other,uptake
Other,Data
Other,regulationOfEnergyMetabolism
Other,oncologicRisk
Other,knownHeterogeneousDisease
Other,3-timeAssessments
Incorporation,descriptiveStudy
Other,profiles
Incorporation,ourPreviousWorkRegardingToPropertiesOfPluronicsWithDifferentPhotosensitizerForPhotodynamicTherapy
Other,erαSignalling
Other,outcome
Other,inherited
Other,percentage
Other,largelyUnknown
Other,satisfied
Other,haveProven
Other,important
Other,hasDeveloped
Interference,delivery
Other,examinations
Other,SVM
Other,CMIA
Other,84Patients
Other,iraqiWomenWhencomparedToWesternWorld
Other,objectives
Other,mostEuropeanCountries
Other,variousStimuli
Other,roughly15
Other,hidden
Other,sparseCombinationOfRiemannianDictionaryAtoms
Other,concentrationsOfVegf-aInComparisonToCa15-3InBreastCancer
Other,type
Other,91Percecnt
Other,failure
Other,widelyUtilized
Interval,postmenopausalPeriodWithDopamineAgonists
Other,type1Diabetes
Resistance,activityOfCellProliferationInBreastCancerCells
Other,bioinformaticAnalysis
Other,member
Analytics,dataAnalytics
Skin,cut-offBalfLevel
Other,trastuzumab/pertuzumab/taxane
Other,findings
Other,presented
Other,mechanisms
Other,prognosis
Other,trastuzumab
Other,secondLargestHmo
Other,consolidativeRadiotherapy
Other,haveYetProven
Other,risk-reducingStrategies
Other,patients'MedicalRecords
Markers,markers
Other,documented
Other,femalePatients
Gene,CK5
Other,hasRecentlyDeveloped
Other,maySteps
Other,conventionalMagneticResonanceImaging
Other,sectionLeads
Polymorphisms,polymorphismsImportant
Other,bevacizumab-relatedCardiotoxicity
Species,Patients
Other,ductalCarcinoma
Other,120BreastCancerPatients
Other,comparable
Other,Resurgery
Disease,breastCancerStaging
Other,1722Comments
Species,mice
Other,changes
Other,differentiallyModulated
Other,most
Other,recommended
Other,healthCareSector
Other,similar
Other,secondaryLymphomatousInvolvement
Other,novelInsightsIntoEpigeneticEvents
Other,breastCancerScreeningProgramme
Other,shouldProcessed
Disease,CLP
Other,mappedToPatientPathway
Other,coverageRates
Other,canineTumours
Other,offered
Chemical,Estrogen
Other,measurementSystem
Other,iterativelyModified
Other,tumorSite-specificInformation
Drugs,conventionalChemotherapyDrugs
Other,balfOfNsclcPatients
Other,49Patients
Other,signalTransductionMoleculesIncludingProteinKinaseC
Other,cases
Extract,commonCauseOfMorbidity
Other,kaplanMeierCurves
Baseline,reducedBaselineLvef
Other,Researchers
Other,longitudinalAssociation
Other,mirnaExpressionProfiles
Other,recentYears
Other,highlightConsiderations
Other,closelyAssociated
Other,theirInteractionsLikeGene-gene
Other,clinicalVisits
Endocrine,patientsWithProstateCancer
Other,complaint
Membrane,paraneoplasticAntibodyPanel
Resistance,breastCancerCellInvasion
Other,secondTumor
Interval,cycle
Other,ultrasound
Other,proteinExpression
Other,advantage
Other,significance
Other,Development
Endocrine,evidenceForEfficacyOfGonadotropin-releasingHormoneAgonists
Interval,highestSeInTotalGroup
Distance,eConcentration
Other,online
Other,femalePatientsWithAd
Other,immediateUnmetNeedInClinicalPractice
Other,part
Endocrine,menopausalHormoneTherapy
Appearance,accuracyOfLesionDetection
Other,modulated
Other,informationNeedsVary
Other,development
Endocrine,dealingWithEndocrineResistanceInPatientsWithBreastCancer
Other,cxcSubtypeOfChemokineSuperfamily
Other,knowledgeGaps
Other,inverseLongitudinalAssociation
Disease,boneLoss
Document,exponentialTiltingSemiparametricModelAccountForNonignorableMissingDataMechanism
Other,switched
Distance,sinceItsFirstDescriptionAtInstituteOfPathologyInKielAgoHasShown
Other,delay
Other,known
Other,correlativeEntities
Other,annualMammographyAssociatedWithEchography
Other,usualCare
Interval,chineseExpertGroup
Membrane,antibodyPanel
Other,immunohistochemicalProliferationMarkerKi67
Other,currentTherapiesAvailable
Other,histopathologicalreports
Exposure,excellentPerformance
Other,sexualityEvidence
Other,It
Food,multiplexAssay
Other,withFourier-domainReconstruction
Other,hasUsedInLeukemia
Incorporation,retrospectiveStudyOfWomenTreatedWithTrastuzumabForHumanEpidermalGrowthFactorReceptor2BreastCancerAtMayoClinicBetweenJanuary12000
Other,understandingOfEmergingConceptsOfTumorBiology
Other,qualitativeApproach
Other,datasets
Other,news
Skin,geneExpressionLevel
Other,mostFrequentMalignancy
Other,ck5/6
Other,program
Other,likelyParaneoplastic
Lymphedema,higherProportionOfPatientsWithLymphedema
Species,participants
Other,diagnosticChallenge
Other,frequentInformationalNeeds
Other,proposedTechniqueResults
Other,historyPhysicalExamFindings
Other,countries
Other,Report
Other,demonstrate
Drugs,developmentOfEffectiveDrugsForTreatmentOfHormone-dependentBreastCancer
Other,included.When
Other,cpgIslands
Other,Depletion
Other,differentPhotosensitizerForPhotodynamicTherapy
Document,content
Other,ovarianMetastases
Resection,Resection
Other,SRS
Other,prophylacticCranialIrradiation
Other,realDataAnalysis
Other,incidence
Other,kind
Collision,theirQuestionableImpactOnMortalityOnIncidenceOfAdvancedTumors
Other,brainMetastases
Other,Ontario
Other,osRate
Other,life
Other,utility
Other,sites
Other,elevatedMitochondrialFission
Other,earlierAges
Document,questionnaireBasedOnAnderson'SdelayModel
Cytology,fine-needleAspirationCytology
Other,inflammatoryBreastDiseaseWithUnknownEtiology
Other,pdgfs/pdgfrsAxis
Gene,PAX8
Other,unclear
Other,ages
Other,alsoUsed
Other,detectedThroughScreeningThroughSigns
Other,medications
Other,estimated
Collision,typeOfCollisionTumor
Other,-1
Sleep,medianAge
Other,CESM
Disease,brainMetastasis
Other,normalCardiacFunction
Other,markedlyUp-regulated
Other,mriImaging
Other,canIncluded
Provision,follow-up
Other,ernGenturis
Other,understanding
Similarities,similaritiesInInformationalNeedsByCancerType
Other,Access
Other,mortalityRates
Other,inContextAppliedInClinicalDiagnosticsInClinicalTrialsForPurposeOfStratification
Other,risk-stratifiedScreeningStrategy
Other,five-yearOsRate
Other,westernBlotAnalysis
Other,healthcareUtilization
Other,enhancedPossibility
Other,controversial
Other,cancerSurvivors
Other,bortezomib-inducedColdAllodynia
Other,applicationsOfRadiomics
Disease,malformation
Other,methylSpecific-multiplexLigationProbeAmplification
Other,oftenRelated
Other,isIdentified
Other,jak-statPathway
Disease,localizedDisease
Other,chemotherapyHormonalTreatment
Other,improvedDiagnosis
Other,highlightImportantConsiderations
Other,potentialTreatmentStrategy
Other,Sutegorization
Other,enrolled
Incorporation,inPresentStudyConductedBetweenMcf-7Tamoxifen-resistantLcc2CellLines
Other,investigated
Other,reproducingKernelHilbertSpace
Other,clinicalCharacteristics
Resistance,cellMigration
Other,otherSubtypesOfBreastCancer
Other,leftParietalRegion
Other,solved
Other,manyPatients
Microenvironment,fundamentalComponentsOfTumorMicroenvironment
Other,placed
Other,dopamineAgonists
Other,192Months
Endocrine,canEffectivelyTreatedByEndocrineTherapy
Other,10-foldCross-validation
Other,cancerCareNetwork
Other,rs5743810ProAllele
Other,83Percecnt
Cytology,intraoperativeScrapeCytology
Other,Rituximab
Appearance,accuracy
Other,simulatedBreastCancer
Other,tumorGrowthInExperimentalModels
Other,inflammatory
Other,statisticallyCorrelated
Endocrine,hormoneReceptor-positiveTumors
Other,real-worldSetting
Other,alsoAssociated
Other,rocCurveAnalysis
Other,surgery
Other,theirOwnParticularity
Other,0.003
Food,goal
Other,long-term
Other,shouldEstablished
Other,overallMedianSurvival
Other,breast
Other,oftenDebated
Gene,HR
Other,microadenomasDataOnLong-termRemissionRate
Other,itsUsefulness
Resistance,action
Oestrogen,oestrogenReceptorΑ
Other,counseling
Other,focal
Other,≥10PercecntReductionInLvef
Other,diseaseDiagnosis
Other,regulated
Other,cutoff
Other,rareTumor
Other,concomitantlyShouldAnalyzed
Other,trend
Interval,controlGroup
Other,binding
Craniotomy,excision
Other,immunohistochemicalTechniques
Other,shanxiProvinceOfChina
Other,simpleLow-costAlternative
Relapse,betterUnderstanding
Other,hereditaryBreast
Consensus,consensusOnAssociationBetweenExposureToDdt
Document,literature
Provision,60ControlPatients
Markers,immunohistochemicalMarkers
Other,ourData
Other,posteriorFossaOfBrain
Other,improvement
Other,genes
Other,moreoverStronglyRecommended
Document,ddtExposure
Other,moreRecommended
Other,napsinAIn7Percecnt
Other,stillDifficult
Other,controlled
Other,post-menopausalWomen
Other,cross-validation
Incorporation,associationsBetweenChangeOfPerceivedWorkAbility
Other,numericalFull-waveSimulation
Other,differences
Other,brain
Other,frequent
Other,commonFinding
Other,needsOfInformationSeekers
Other,riskOfDeath
Microenvironment,pro-tumorigenicMicroenvironment
Other,little
Other,PF
Other,descriptive-analyticCross-sectionalType160FemalePatientsWasselected
Hyperglycemia,effect
Other,salpingo-oophorectomy
Other,featureMining
Other,usuallyLong-term
Other,fiveMutationCarriers
Relapse,reductionOfRelapse
Other,bioimpedanceAnalysis
Other,publicHealthChallenge
Other,protected
Other,earlyCancerDiagnosis
Other,canIncludedInDifferentialDiagnosisOfMasses
Gene,progranulin
Other,hereditaryCausesOfChorea
Other,developmentOfGraphicallyTailoredScreeningTool
Other,useful
Other,need
Covariance,proposedCovariance
Other,painlessLumpInBreastAccountingFor688PercecntOfPatients
Other,indicationsForRisk-reducingSurgery
Other,pairedTumor
Other,growthImplicatedInTumorigenesis
Other,therapeuticEffectsInBreastCancer
Other,cylindricalGeometries
Gene,MORC4
Other,synthesisMethods
Other,essential
Other,appropriateQuality
Disease,krukenbergTumors
Other,knowledge
Literacy,lowHealthLiteracy
Other,transitionProbabilities
Literacy,definitionOfHealthLiteracy
Other,years
Other,decreased
Other,brainMetastasisFromPapillaryThyroidCarcinoma
Other,PCI
Other,feature
Other,reverseTranscriptionQuantitativePolymeraseChainReaction
Other,tumorEasily
Other,earlyDiagnosis
Interval,fieldOfMedicalImagesDiagnosis
Other,haveProposed
Other,survival
Relapse,≥10PercecntDecline
Disease,lungCancer
Other,results
Other,harmToHealthAmongRuralWomenWithIncrementalCost-effectivenessRatio
Other,breastCancerCare
Other,potential
Other,≥Reduction
Other,riskOfBreastCancerInAdulthood
Other,perceptionOfQualityOfCareProvidedByCancerCareNetworkForEarlyDetectionOfBreastCancer
Other,reviewed
Other,pfBiomarkers
Other,compared
Images,featuresFromImages
Other,varyingAmountsOfSolidComponents
Other,simulation
Exposure,performance
Other,reverseActiveLearningForClassificationOfHealthyBreastTissue
Other,womenInWorld
Relapse,breastCancerRelapse
Other,regulationOfNras
Other,potentialImportanceAsModelsForHumanBreastCancer
Other,trastuzumabTherapyForBreastCancer
Other,10NeedContents
Other,China
Other,critical
Other,networkOutput
Other,proteinKinaseC/extracellularSignal-regulatedKinasePathway
Other,suppressionOfBreastCancer
Other,howeverShouldPerformed
Other,algorithm
Other,growth
Other,terms
Other,studies
Other,currentUtilizedHistopathologicBiomarkers
Other,costData
Disease,LVEF
Other,crucial
Other,cutoffValues
Other,27-36MillionPatients
Other,distributions
Disease,cowdenSyndrome
Other,nature
Other,expressed
Other,bindingSites
Other,pathologistAnnotation
Other,higher
Other,devastatingDiagnosis
Resistance,applicationOfPhase-sensitiveTechniques
Other,ideallyPlaced
Other,stableDrug-carrierBinding
Other,importantPhenotypicFeatureOfCdh1GermlineMutationCarriers
Other,locoregionalDiseaseOfUnspecifiedLocation
Other,pathologicalResults
Relapse,medianTimeToCnsRelapseOf31Years
Other,furtherResearch
Other,pathologicalSpecimen
Other,taken
Chemical,Baicalin
Other,five-yearMetastasis-free
Markers,diagnosticValueOfMarkers
Other,dissectionOfLymphNodes
Other,required
Other,lisbonRegion
Other,lowIncomeCountries
Other,thereforeRequired
Drugs,chemotherapyDrugs
Other,moreoverAssociated
Other,10Centers
Other,protectiveRoleOfRs5743810
Other,highBurdenOfCancer
Other,painless
Lifestyle,itsWater-bathSetup
Other,secondValuedApproach
Other,youngMexicanWomen
Other,30Cm
Neuropathy,relationToOccurrenceOfOsteoporosisAmongVariousEthnicGroups
Other,23Patients
Other,willUsed
Baseline,patientsWithReducedBaselineLvef
Disease,non-smallCellLungCancer
Other,Diseases
Extract,commonCause
Other,TAAs
Other,polymorphism
Other,pertinent
Disease,choreiformMovements
Other,improvedDiagnostics
Other,secretion
Cavernous,cavernousMalformationInduction
Other,function
Food,differencesInAssayPerformance
Resistance,breastCancerCellMigration
Neuropathy,irregularHyperintenseLesion
Other,77
Resistance,vitaminDActivity
Sprays,increaseWithNumberOfSprays
Other,developmentOfManyMetabolicDisorders
Other,imaging
Other,geometries
Other,observed
Disease,OS
Users,12331Users
Other,imbalance
Other,p
Other,secondaryLymphoidTissueDevelopmentOfLymphocytesWithinMicrocompartmentsOfTissue
Other,characteristics
Other,none
Other,approach
Other,Images
Document,document
Computer,Computer
Erythematous,characterizedByAcuteAppearanceWithErythematousPlaqueSometimesHotMoreOftenSituatedInPrimaryTumorVicinity
Other,immediateUnmetNeed
Other,manifold
Other,innateImmuneSystems
Other,rareSubtypeOfDllWithLimitedDataOnPatternsOfFailure
Other,sexualityMoreEvidence
Other,created
Other,tanUsage
Articles,Articles
Other,SVM-BRC
Food,heartFailureParticularly
Other,survivalData
Other,visits
Polymorphisms,polymorphisms
Other,followed
Other,estrogen-aloneArmOfWhi
Other,downregulatedIn
Images,images
Users,users
Relapse,continuousPatternOfRelapse
Other,992PercecntOfCases
Other,0.02
Other,doublingTimeOfOccult
Cavernous,twoCasesOfCavernousMalformationFormationYears
Other,andfemales
Other,Treatment
Other,challenging
Other,its
Other,diagnosisOfCancer
Disease,HT
Other,expression
Other,recentlyHaveUsedAsBiomarkers
Disease,anxiety
Other,implications
Other,v-gCalciumChannelBindingAntibodies
Other,growingProblem
Other,ssessedByWoundHealingAssayinAddition
Other,otherImagingCharacteristics
Other,promising
Disease,cancerGenomeAtlas
Skin,levelExamination
Collision,collisionTumorWithBreastCancerMetastasis
Other,onlyIndicative
Extract,benefit
Other,bLymphocyteChemoattractant
DNA,dnaMethylation
Other,performed
Gene,VEGF-D
Other,histopathologicalAnalysis
Other,proposedHowever
Disease,tumors
Other,metastaticBreastCancer
Other,recurrence
Other,itsReceptorLocatedInManyCellsOfBody
Dysplasia,binaryLogisticRegressionModels
Other,broadcasted
Areola,itSideEffects
Appearance,caseOf75-year-oldPatientWithDuctalInfiltratedCarcinoma
Other,receiving
Other,She
Cytology,cytology
Resistance,resistance
Other,6084Years
Food,symptomaticHeartFailure
Other,age-basedScreeningPrograms
Other,projected
Other,itsImportantRole
Other,histopathologicalDiagnostics
Obstacle,hazardRates
Endocrine,pituitaryFunction
Other,FPs
Macroadenomas,usuallyMacroadenomas
Other,mostPatients
Other,regressionAnalyses
Other,-916
Other,geneticMalignancyPredispositionSyndrome
Other,tissueTumors
Other,therapeuticallyEffective
Other,sevenWomen
Other,directlyAffectedByOverexpressionDownRegulationOfManyMirnas
Other,combinedAnalysis
Other,significantConnection
Other,southernPortuguese
Other,novelty
Other,comparison
Other,main
Other,Targeting
Other,mechanism
Other,typicalHormone-dependentTumor
Plasticity,comparableToContrast-enhancedMriInTermsOfSensitivityAtFractionOfCost
Other,promoterdnaMethylation
Other,developmentOfMetabolicDisorders
Other,12
Other,estrogenReceptor
Other,project
Other,breastTumorigenesis
Incorporation,inPresentWorkHasProposedForBreastCancerDiagnosis
Incorporation,retrospectiveObservationalStudyOf264Her2-positiveAdvancedBreastCancer
Other,increasedMalignantPotential
Other,Validation
Chemical,bortezomib
Other,relapseRates
Other,public
Other,determined
Other,thenDefinedInReproductiveYears
Other,resultsAberrantExpression
Other,retrospectivelyReviewed
Other,synchrotronSources
Disease,erysipelatoidCarcinoma
Other,additionallyCorrelated
Other,assessments
Other,popular
Plasticity,one-waySensitivityAnalyses
Nondestructive,nondestructiveTests
Other,ERN
Other,optimalCutoffValues
Skin,level
Other,n-typeVoltage-gatedV-gCalciumChannelBindingAntibodies
Document,nsaidExposure
Other,biomarkers
Plasticity,sensitivityAnalysesresults
Other,clinicalBreastExamination
Other,immune-mediatedCancer-associatedDisorders
Other,usuallyPerformed
Other,medical
Other,160Patients
Disease,invasiveBreastCarcinoma
Other,Non-linearity
Other,fpReduction
Other,practitionerDecisionmaking
Other,paradigmaticExamples
Other,adjuvantAnastrozole
Other,unbiasedRnaSequenceAnalysis
Other,contrastRatio
Other,pulmonaryMetastases
Other,increasedRisk
Other,Co-existence
Other,treated
Chemical,tamoxifen
Other,localizedDescription
Literacy,influenceOfHealthLiteracyOnPathwayToCancerDiagnosis
Distance,boneDensity
Species,patient
Other,state-of-the-artAlgorithms
Other,interview
Other,drugTherapy
Other,positive
Lifestyle,proposedTotal-variationSchemeWithSpatially-varyingAnisotropicWeightingCompensateForGeometricBiasFromLimitedAngleImagingSetup
Other,portugueseWomen
Gene,microRNA-22
Other,breastCancerTissues
Other,hypomethylated
Other,humanLife
Relapse,riskOfBreastRelapse
Other,relatedResearchDataOfDiagnosisOfInoperableLocallyAdvancedBreastCancer
Applicability,clinicalApplicabilityOfOurMethodInBreastCancerImagingSetting
Other,Literature
Other,hasAlreadyAssociatedWithDifferentCancersNon-hodgkin'sLymphoma
Other,collected
Disease,lungAdenocarcinomas
Other,properFunctioningOfSkeletalSystem
Other,overview
Other,acceptableSafetyMargins
Other,volumetricMeasurementSystem
Other,rnaKnockdown
Other,unusual
Other,following
Resistance,capacity
Species,Fisher
Other,Cryopreservation
Appearance,receiverOperatingCharacteristic
Other,contrast-enhancedSpectralMammography
Other,mStage
Other,screeningStrategy
Other,preventionOfDiagnosedBreastCancerInEstrogen-aloneArmOfWhi
Other,sosValues
Other,appropriateInterpretation
Collision,recurrentWords
Other,tests
Other,high
Other,Europe
Interval,fieldOfBreastCancerDetection
Other,breastCancerConfinedWithinMammaryDuctsSurrounded
Endocrine,adjuvantEndocrineHormonalTherapy
Other,found
Other,lossOf020Quality-adjustedLifeYears
Other,potentialSourcesOfVariance
Lymphedema,unilateralBreastCancer-relatedLymphedema
Other,diffuse
Relapse,betterUnderstandingOfRisksAssociatedWithM
Other,proportion
Other,expressionOfOtherBiomarkers
Other,focalNeurologicDeficit
Resistance,capacityForEarlyDiagnosisOfBreastCancer
Other,Utilization
Disease,UC
NSAID,nsaidUsers
Distance,firstTime
Obstacle,adjustedHazardRatio
Other,forwardProblem
Other,percecnt
Other,effects
Interval,absence
Other,questionnaireAdministeredOnJapan'sLargestCancerInformationWebsite
Other,un-recognized
Other,21Months
Other,tumorNecrosisFactor
Other,enforcedExpression
Other,priorities
Other,tumorCells
Plasticity,sensitivityOf786PercecntRespectively
Other,RT
Other,two-thirdsOfBreastCancerCases
Other,able
Other,inMultivariateModelsRelatedToPerformanceStatus
Disease,pain
Other,specificCircumstances
Other,increase
Other,onEsophagogastroduodenoscopyIdentifiedInAntrum
Other,especiallyFrequentLateRelapsesInCnsBreast
Other,CTIBL
Other,breastCancerStudies
Other,consultations
Other,shouldAdministered
Other,complexSemisolidMassesWithVaryingAmountsOfSolidComponents
Provision,provision
Extract,cause
Other,status
Other,inexpensiveTechnique
Other,coding
Other,careProvider
Other,appropriateAllocationOfResearchFunding
Gene,Drp1
Other,contrastEnhancement
Other,rnaSequenceAnalysis
Other,mutations
Other,65Months
Other,presentation
Disease,micrometastasis
Other,differentProtocols
Other,double-maintenanceTherapy
Skin,aromataseInhibitor-inducedBoneLoss
Other,mostPrevalentCancer
Other,oneRegion
Other,theirSelection
Other,44Percecnt
Other,dataOn108Pb-dllPatientsFrom21ChineseMedicalCenters
Other,healthcareCost
Other,125DogSeraSamplesIncluding75MammaryTumourSera
Other,symptoms
Other,shouldProceede
Other,undergoing
Other,lowRiskLesions
Other,individuals
Other,data
Other,wereIncludedIn
Other,mitochondrialFission
Other,node
Other,prophylacticBilateralSalpingo-oophorectomy
Markers,solubleMarkers
Other,volume
Other,methods
Other,13PercecntOfDeaths
Disease,metastases
Other,syndromes
Interval,g1/s-phaseCellCycleArrest
Disease,secondaryLymphedema
Species,Women
Other,world
Other,ranging
Regions,enhancerRegions
Other,expressionInBreastCancer
Membrane,combinedPanel
Other,variousArtifactsIntroducedDuringSlidePreparation
Other,inclusionCriteria
Interference,shouldEstablishedBetweenScreeningWithImplementationOfRobustQualityAssurance
Disease,neuropathies
Document,balfContent
DNA,aberrantDnaMethylation
Other,roleOfImage-basedTextureFeaturesAsNoninvasivePrognosticBiomarkers
Other,flankingCgi
Other,clinicalDiagnosticPathways
Distance,firstDataOnPre-diagnosisConcentrationsOfSrankl
Document,balfContentOfProgranulinIn46NsclcPatientsBeforeChemotherapy
Food,followedFromDateOfFirstDiagnosisOfAdToEndOf2013
Other,wereDiagnosedWith
Provision,disturbance
Other,respectivelyFound
Other,bilateralInvolvement
Other,based
Other,multiparametricMri
Other,management
Other,Belgium
Other,510YearsAfterSurgery
Other,challenge
Other,canHeavilyInfluenced
Other,insights
HER-2,adultsWithHer-2PositiveBreastCancer
Other,assessed
Other,functions
Other,miR-34s
Other,related
Other,Probes
Other,secretionOfTumorNecrosisFactor
Other,importantRoles
Other,contralateralBreast
Other,highGlut1Expression
Other,possibility
Other,it
Other,reported
Other,survivalOfCellsInVitroAndInVivo
Other,findingsFromStudies
Other,furtherStudies
Endocrine,endocrineResistance
Other,debated
Other,hugeImprovement
Other,treatments
Provision,site-specificBindingLeadingToImprovedCancerTreatmentWithMinimalRisksToNormalCells
Other,20PercecntForGata3
Other,transformed
Incorporation,perceivedWorkAbility
Disease,malignantPleuralEffusion
Other,haveBackbone
Other,ourProposedMethod
Other,Applications
Other,thirdInTermsOfSpecificMortality
Other,cancerProgression
Other,inCanadaOfferedInOrganizedPrograms
Other,transcoelomic
Other,fundamentalComponents
Other,evaluated
Other,sosReconstruction
Other,oncogenes
Other,amino-terminalFragment
Other,research
Other,moreoverPoor
Other,largestCancerInformationWebsite
Distance,firstTimeIn1984
Other,canines
Other,identified
Disruption,intrinsicDisruption
Other,presence
Collision,impactOfStableKnockdownOfSmarcad1OnHumanBreastCancerCellProgression
Other,widelyKnown
Other,up-regulated
Other,involvement